MedTrace Logo

TTS Esophageal HILZO Stent: A Safety and Feasibility Study

NCT03269903 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-09-01

No results posted yet for this study

Summary

A multicenter non-randomized prospective clinical study assessing the safety and feasibility of the esophageal through-the-scope HILZO Covered self-expandable metal stent placement for palliation of malignant dysphagia

Conditions

  • Esophagus Cancer

Interventions

DEVICE

HILZO esophageal stent

A fully covered esophageal self-expandable metal stent for malignant dysphagia

Sponsors & Collaborators

  • Kebomed B.V.

    collaborator UNKNOWN

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Peter Siersema, professor · Radboud University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-03-01
Completion
2018-09-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03269903 on ClinicalTrials.gov